FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963733265> ?p ?o ?g. }

• W1963733265 endingPage "177" @default.
• W1963733265 startingPage "177" @default.
• W1963733265 abstract "Finding the optimal strategy for Pneumocystis carinii prophylaxis in patients with human immunodeficiency virus infection can be problematic. Several prophylactic regimens are available, but their relative efficacy and tolerance are not well understood.A meta-analysis overviewed 35 randomized trials comparing different regimens for P carinii prophylaxis directly or with placebo. Analyses were based on intention-to-treat. On-treatment data were also analyzed when available.Regardless of dose, sulfamethoxazole-trimethoprim was almost universally effective for patients who tolerated it. The risk of discontinuing sulfamethoxazole-trimethoprim because of side effects decreased by 43% (95% confidence interval, 30% to 54%) if one double-strength tablet was given three times a week instead of daily. For dapsone, among 100 patients given 100 mg daily instead of twice a week for 1 year (primary prophylaxis), seven fewer patients would develop P carinii pneumonia, but 17 more would have significant toxic reactions. Aerosolized pentamidine was well tolerated regardless of the dose used. Prophylaxis failures might be halved if the dose of aerosolized pentamidine were doubled. Compared with aerosolized pentamidine, oral regimens prevented 73% (95% confidence interval, 57% to 82%) of toxoplasmosis events by on-treatment analysis, but only 33% (95% confidence interval, 12% to 50%) by intention-to-treat. No significant difference in mortality was demonstrated between different regimens.Sulfamethoxazole-trimethoprim is the superior regimen, and low doses could improve tolerance without losing effectiveness for primary prophylaxis. Low doses of dapsone reduce toxic effects, but at the expense of some loss of efficacy. There are few data on the use of low-dose regimens for secondary prophylaxis. High doses of aerosolized pentamidine may improve the efficacy of this regimen. Aerosolized pentamidine is inadequate for prevention of toxoplasmosis, and strategies that improve the tolerance of oral regimens may increase effectiveness in preventing toxoplasmosis." @default.
• W1963733265 created "2016-06-24" @default.
• W1963733265 creator A5040607821 @default.
• W1963733265 creator A5045896185 @default.
• W1963733265 creator A5070446713 @default.
• W1963733265 creator A5091652325 @default.
• W1963733265 creator A5091669022 @default.
• W1963733265 date "1996-01-22" @default.
• W1963733265 modified "2023-10-03" @default.
• W1963733265 title "A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens" @default.
• W1963733265 cites W129572286 @default.
• W1963733265 cites W137040874 @default.
• W1963733265 cites W1963516542 @default.
• W1963733265 cites W1967365647 @default.
• W1963733265 cites W1971021024 @default.
• W1963733265 cites W1973948212 @default.
• W1963733265 cites W1981366475 @default.
• W1963733265 cites W1982098070 @default.
• W1963733265 cites W1985565019 @default.
• W1963733265 cites W1994946938 @default.
• W1963733265 cites W2001710615 @default.
• W1963733265 cites W2026579627 @default.
• W1963733265 cites W2027563386 @default.
• W1963733265 cites W2034214854 @default.
• W1963733265 cites W2046695379 @default.
• W1963733265 cites W2048530100 @default.
• W1963733265 cites W2050463570 @default.
• W1963733265 cites W2052954384 @default.
• W1963733265 cites W2052984045 @default.
• W1963733265 cites W2059125048 @default.
• W1963733265 cites W2061320778 @default.
• W1963733265 cites W2063169348 @default.
• W1963733265 cites W2064072228 @default.
• W1963733265 cites W2068584061 @default.
• W1963733265 cites W2083817362 @default.
• W1963733265 cites W2086380193 @default.
• W1963733265 cites W2094247432 @default.
• W1963733265 cites W2095575164 @default.
• W1963733265 cites W2107328434 @default.
• W1963733265 cites W2114210513 @default.
• W1963733265 cites W2116272542 @default.
• W1963733265 cites W2131406035 @default.
• W1963733265 cites W2141401653 @default.
• W1963733265 cites W2143294512 @default.
• W1963733265 cites W2150000105 @default.
• W1963733265 cites W2150290224 @default.
• W1963733265 cites W2168853626 @default.
• W1963733265 cites W2283181605 @default.
• W1963733265 cites W2326288814 @default.
• W1963733265 cites W2327914544 @default.
• W1963733265 cites W2335153389 @default.
• W1963733265 cites W2336509748 @default.
• W1963733265 cites W2337303087 @default.
• W1963733265 cites W2338892227 @default.
• W1963733265 cites W2520146681 @default.
• W1963733265 cites W252399093 @default.
• W1963733265 cites W27878237 @default.
• W1963733265 cites W2022723856 @default.
• W1963733265 cites W2338529468 @default.
• W1963733265 doi "https://doi.org/10.1001/archinte.1996.00440020081010" @default.
• W1963733265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8546551" @default.
• W1963733265 hasPublicationYear "1996" @default.
• W1963733265 type Work @default.
• W1963733265 sameAs 1963733265 @default.
• W1963733265 citedByCount "155" @default.
• W1963733265 countsByYear W19637332652012 @default.
• W1963733265 countsByYear W19637332652013 @default.
• W1963733265 countsByYear W19637332652014 @default.
• W1963733265 countsByYear W19637332652015 @default.
• W1963733265 countsByYear W19637332652016 @default.
• W1963733265 countsByYear W19637332652017 @default.
• W1963733265 countsByYear W19637332652018 @default.
• W1963733265 countsByYear W19637332652019 @default.
• W1963733265 countsByYear W19637332652020 @default.
• W1963733265 countsByYear W19637332652021 @default.
• W1963733265 countsByYear W19637332652022 @default.
• W1963733265 countsByYear W19637332652023 @default.
• W1963733265 crossrefType "journal-article" @default.
• W1963733265 hasAuthorship W1963733265A5040607821 @default.
• W1963733265 hasAuthorship W1963733265A5045896185 @default.
• W1963733265 hasAuthorship W1963733265A5070446713 @default.
• W1963733265 hasAuthorship W1963733265A5091652325 @default.
• W1963733265 hasAuthorship W1963733265A5091669022 @default.
• W1963733265 hasConcept C126322002 @default.
• W1963733265 hasConcept C141071460 @default.
• W1963733265 hasConcept C142724271 @default.
• W1963733265 hasConcept C203014093 @default.
• W1963733265 hasConcept C204787440 @default.
• W1963733265 hasConcept C27081682 @default.
• W1963733265 hasConcept C2776688490 @default.
• W1963733265 hasConcept C2777530519 @default.
• W1963733265 hasConcept C2777559004 @default.
• W1963733265 hasConcept C2777640609 @default.
• W1963733265 hasConcept C2777914695 @default.
• W1963733265 hasConcept C2779425571 @default.
• W1963733265 hasConcept C2780728791 @default.
• W1963733265 hasConcept C2781413609 @default.
• W1963733265 hasConcept C2993443204 @default.

• next